Friday, September 04, 2026 1:30 PM ET
1 day ago
Cramer: Here are 3 defensive stock market moves I'm making as oil and rates surge2 days ago
We're adding 2 stocks to our Bullpen watchlist because they meet these criteria2 days ago
This medical device stock looks like a gift for patient investors2 days ago
August was the month of the comeback kids. Cramer reviews what drove the biggest winners3 days ago
Trump strikes new drug pricing deals with nine midsized drugmakers3 days ago
BioCryst is profitable. Now it wants to buy more rare disease drugs7 days ago
How Taylor Farms became integral to America's food supply system7 days ago
FDA approves daily HIV pill from Gilead designed to simplify treatment7 days ago
HHS plans new FDA leadership roles for technology and drugs, sources say7 days ago
Why vaccination rates are falling in the U.S.10 days ago
BioMarin to acquire Alesta Therapeutics for $275 million14 days ago
Cancer vaccine from Moderna, Merck shows promise in late-stage trial; both stocks soar15 days ago
Hims & Hers CEO says FTC lawsuit misunderstands how the company works17 days ago
The startup using AI to help rare disease families develop custom treatments17 days ago
Court rules companies can't import Gilead medications from overseas17 days ago
Novo Nordisk CEO defends lawsuit against Eli Lilly: 'Competition has to be fair'22 days ago
Trump administration ends Medicaid, CHIP funding for gender-affirming care for children23 days ago
We're lifting our price target on Cardinal Health after issuing rosy profit guidance23 days ago
Trump wants to split the MMR vaccine. Experts say that's unlikely23 days ago
Jazz Pharmaceuticals to buy Actio Biosciences for $820 million24 days ago
Eli Lilly takes weight-loss pill battle global24 days ago
Trump signs order calling for fewer childhood vaccines, falsely linking shots to autism24 days ago
New genetic tests are catching rare diseases before symptoms start24 days ago
Why we like Boeing's latest deal — plus, what to expect from this health stock24 days ago
Hunter Biden says Joe Biden's cancer has spread further, 'very painful'25 days ago
Cyclospora fears lead consumers to lose their appetite for salads27 days ago
Jim Cramer highlights 5 investing themes — and the stocks to buy for each28 days ago
Sen. Mitch McConnell says he's left rehab, will work from home28 days ago
CAMP4 advances rare disease treatment for SYNGAP1 into human trials28 days ago
Divide between Eli Lilly and Novo Nordisk is widening after latest earnings28 days ago
AstraZeneca may buck a decade of pharma strategy to buy U.S. scale29 days ago